Evidence map›Paper›PMID 36114913›Full record

ArticleActa neurochirurgica2022

The effect of intraoperative intrathecal opioid administration on the length of stay and postoperative pain control for patients undergoing lumbar interbody fusion.

Alan Villavicencio, Hash Brown Taha, E Lee Nelson, Sharad Rajpal, Kara Beasley, Sigita Burneikiene

Abstract read
PubMed Publisher
In one paragraph

Article in Acta neurochirurgica, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Alan VillavicencioBoulder Neurosurgical Associates, 4743 Arapahoe Avenue, Suite 202 Boulder, CO 80303, CO, Boulder, USA.
Hash Brown TahaDepartment of Integrative Physiology, University of Colorado-Boulder, Boulder, CO, USA.
E Lee NelsonBoulder Neurosurgical Associates, 4743 Arapahoe Avenue, Suite 202 Boulder, CO 80303, CO, Boulder, USA.
Sharad RajpalBoulder Neurosurgical Associates, 4743 Arapahoe Avenue, Suite 202 Boulder, CO 80303, CO, Boulder, USA.
Kara BeasleyBoulder Neurosurgical Associates, 4743 Arapahoe Avenue, Suite 202 Boulder, CO 80303, CO, Boulder, USA.
Sigita BurneikieneBoulder Neurosurgical Associates, 4743 Arapahoe Avenue, Suite 202 Boulder, CO 80303, CO, Boulder, USA. sigitab@bnasurg.com.ORCID 0000-0002-6508-4140
Boulder Neurosurgical & Spine Associates · USUniversity of Colorado Boulder · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeIn an effort to control postoperative pain more effectively in spinal fusion patients, intraoperative intrathecal morphine (ITM) administration is gaining popularity and acceptance with clinicians. This study seeks to determine the impact of intraoperative intrathecal opioid (ITO) administration following lumbar fusion surgery on postoperative pain and length of hospitalization as primary outcomes. Secondary outcomes will investigate postoperative opioid intake and side effects.

methodsThe retrospective analysis of collected data was performed. The study compared patients undergoing one- or two-level transforaminal interbody fusions between 2019 and 2021 who intraoperatively received two different ITO doses (n = 89) vs. the reference group (n = 48) that did not receive ITO. The patients in the ITO group received either 0.2 mg (n = 44) of duramorph or 0.2 mg duramorph + 50 mcg fentanyl (n = 45). The effect of ITO was evaluated for the first four postoperative days (POD) on pain scores (visual analog scale), length of stay (LOS, hours) and opioid requirement (MED, morphine equivalent dose).

resultsIn the ITO group, a significant reduction of postoperative pain scores (t(99) = 4.3, p < 0.001) and opioid intake (t(70) = 2.49, p = 0.015) was noted on POD1. Cohen's d effect sizes were 0.76 and 0.50, meaning that postoperative pain and MED intake were reduced by about ¾ to ½ standard deviations (SD) in the ITO group. Further, multivariate regression models revealed that ITO administration predicted lower postoperative pain scores for the two PODs (β =  - 0.83, p < 0.001; β =  - 0.63, p = 0.022) and MED intake for the first two PODs (β =  - 20.8, p = 0.047; β =  - 16.4, p = 0.030). Mean LOS was 15.4 h less in the ITO group (mean ± SD, 63.4 ± 37.1 vs. 78.8 ± 39.6, p = 0.10).

conclusionsIn conclusion, our study provides results in a large sample of patients undergoing transforaminal lumbar fusions. The results demonstrated that ITO administration is effective in reducing POD1 pain scores and POD1-2 opioid requirement while not increasing the risk of any opioid-related side effects.

Indexed as

Analgesics, OpioidSpinal FusionHumansInjections, SpinalLength of StayMorphinePostoperative PainRetrospective StudiesAnalgesics, OpioidMorphineIntrathecal morphineLumbar fusionOpioidsPostoperative pain

Identifiers

PMID36114913
OpenAlexW4296157612

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.